Submit newsAdvertise & rates  22°C Johannesburg Contact us
Press offices
Medical news

Yale study solves another molecular mystery of Alzheimer's

26 Jul 2012 15:44Submit a commentBizLike
Amyloid beta peptides have long been implicated in the development of Alzheimer's disease, but exactly how these tiny proteins wreak havoc in aging brains is not fully understood.
In this week's journal Nature Neuroscience, Yale researchers led by Stephen Strittmatter, the Vincent Coates Professor of Neurology and professor of neurobiology, describe the molecular events triggered when amyloid beta joins with cellular prion proteins. The combination triggers damage to both neurons and connections between brain cells that are common in Alzheimer's. The researchers hope that the description of these molecular steps will provide targets for drugs that would halt progression of the disease.
 
More options
LEGAL DISCLAIMER: This Message Board accepts no liability of legal consequences that arise from the Message Boards (e.g. defamation, slander, or other such crimes). All posted messages are the sole property of their respective authors. The maintainer does retain the right to remove any message posts for whatever reasons. People that post messages to this forum are not to libel/slander nor in any other way depict a company, entity, individual(s), or service in a false light; should they do so, the legal consequences are theirs alone. Bizcommunity.com will disclose authors' IP addresses to authorities if compelled to do so by a court of law.

Subscribe to industry newsletters


Bizcommunity has over 400 industry contributors and we always welcome further contributions and contributors.

Subscribe

Receive free email newsletter

Make us your homepageAdd us to your favoritesRSS feedGet biz on your phoneFollow us

Invite

Tell a friend about us